Skip to main content Skip to section navigation Skip to footer
  • ViraxImmune™
  • Products
    • All
    • ELISpot Kits
    • ImmuneSelect Peptide Pools
  • Services
  • Media
  • Leadership
  • Contact
  • Investor Relations
Menu
  • ViraxImmune™
  • Products
    • All
    • ELISpot Kits
    • ImmuneSelect Peptide Pools
  • Services
  • Media
  • Leadership
  • Contact
  • Investor Relations
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Dec 21, 2023 7:30am EST

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 18, 2023 7:30am EST

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 14, 2023 7:30am EST

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Sep 12, 2023 7:30am EDT

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 01, 2023 7:30am EDT

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Aug 03, 2023 7:30am EDT

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Jul 18, 2023 7:30am EDT

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Jun 14, 2023 7:30am EDT

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

May 04, 2023 7:30am EDT

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Apr 19, 2023 7:30am EDT

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

BioCity Glasgow
Bo’Ness Road, Newhouse
Lanarkshire
ML1 5UH
United Kingdom

Quick links

  • Discover ViraxImmune™ Novel PAIS Diagnostic Development
  • Products
  • Custom Immunology Services By Virax Biolabs
  • Terms and Conditions
  • News And Media Updates From Virax Biolabs
  • Meet Virax Biolabs’ Leadership Team and Advisory Board
  • Contact
  • Investor Relations
  • Discover ViraxImmune™ Novel PAIS Diagnostic Development
  • Products
  • Custom Immunology Services By Virax Biolabs
  • Terms and Conditions
  • News And Media Updates From Virax Biolabs
  • Meet Virax Biolabs’ Leadership Team and Advisory Board
  • Contact
  • Investor Relations

Follow us

Facebook Twitter Linkedin Instagram
© All Rights Reserved, Virax Biolabs 2024 | Privacy Policy | Terms of Service